330 related articles for article (PubMed ID: 21414049)
1. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
Marsella R; Olivry T; Carlotti DN;
Vet Dermatol; 2011 Jun; 22(3):239-48. PubMed ID: 21414049
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of filaggrin polyclonal antibody in atopic and normal beagles.
Marsella R; Samuelson D; Harrington L
Vet Dermatol; 2009 Oct; 20(5-6):547-54. PubMed ID: 20178493
[TBL] [Abstract][Full Text] [Related]
3. Unravelling the skin barrier: a new paradigm for atopic dermatitis and house dust mites.
Marsella R; Samuelson D
Vet Dermatol; 2009 Oct; 20(5-6):533-40. PubMed ID: 20178491
[TBL] [Abstract][Full Text] [Related]
4. Is the skin barrier abnormal in dogs with atopic dermatitis?
Olivry T
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):11-6. PubMed ID: 21835476
[TBL] [Abstract][Full Text] [Related]
5. Altered mRNA and protein expression of filaggrin in the skin of a canine animal model for atopic dermatitis.
Santoro D; Marsella R; Ahrens K; Graves TK; Bunick D
Vet Dermatol; 2013 Jun; 24(3):329-36, e73. PubMed ID: 23668858
[TBL] [Abstract][Full Text] [Related]
6. Gene expression in canine atopic dermatitis and correlation with clinical severity scores.
Wood SH; Clements DN; Ollier WE; Nuttall T; McEwan NA; Carter SD
J Dermatol Sci; 2009 Jul; 55(1):27-33. PubMed ID: 19394200
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
[TBL] [Abstract][Full Text] [Related]
8. Clinical comparison of human and canine atopic dermatitis using human diagnostic criteria (Japanese Dermatological Association, 2009): proposal of provisional diagnostic criteria for canine atopic dermatitis.
Terada Y; Nagata M; Murayama N; Nanko H; Furue M
J Dermatol; 2011 Aug; 38(8):784-90. PubMed ID: 21434981
[TBL] [Abstract][Full Text] [Related]
9. Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls.
Reiter LV; Torres SM; Wertz PW
Vet Dermatol; 2009 Aug; 20(4):260-6. PubMed ID: 19659537
[TBL] [Abstract][Full Text] [Related]
10. Gene (mRNA) expression in canine atopic dermatitis: microarray analysis.
Merryman-Simpson AE; Wood SH; Fretwell N; Jones PG; McLaren WM; McEwan NA; Clements DN; Carter SD; Ollier WE; Nuttall T
Vet Dermatol; 2008 Apr; 19(2):59-66. PubMed ID: 18336422
[TBL] [Abstract][Full Text] [Related]
11. Are transepidermal water loss and clinical signs correlated in canine atopic dermatitis? A compilation of studies.
Marsella R
Vet Dermatol; 2012 Jun; 23(3):238-e49. PubMed ID: 22575022
[TBL] [Abstract][Full Text] [Related]
12. Alteration of stratum corneum ceramide profiles in spontaneous canine model of atopic dermatitis.
Yoon JS; Nishifuji K; Sasaki A; Ide K; Ishikawa J; Yoshihara T; Iwasaki T
Exp Dermatol; 2011 Sep; 20(9):732-6. PubMed ID: 21649737
[TBL] [Abstract][Full Text] [Related]
13. Atopic dermatitis in the domestic dog.
Pucheu-Haston CM
Clin Dermatol; 2016; 34(2):299-303. PubMed ID: 26903192
[TBL] [Abstract][Full Text] [Related]
14. Does filaggrin expression correlate with severity of clinical signs in dogs with atopic dermatitis?
Marsella R
Vet Dermatol; 2013 Apr; 24(2):266-e59. PubMed ID: 23398596
[TBL] [Abstract][Full Text] [Related]
15. Review: Role of genetics and the environment in the pathogenesis of canine atopic dermatitis.
Bizikova P; Pucheu-Haston CM; Eisenschenk MN; Marsella R; Nuttall T; Santoro D
Vet Dermatol; 2015 Apr; 26(2):95-e26. PubMed ID: 25703290
[TBL] [Abstract][Full Text] [Related]
16. Review: The role of antibodies, autoantigens and food allergens in canine atopic dermatitis.
Pucheu-Haston CM; Bizikova P; Eisenschenk MN; Santoro D; Nuttall T; Marsella R
Vet Dermatol; 2015 Apr; 26(2):115-e30. PubMed ID: 25728611
[TBL] [Abstract][Full Text] [Related]
17. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs.
Piekutowska A; Pin D; Rème CA; Gatto H; Haftek M
J Comp Pathol; 2008 May; 138(4):197-203. PubMed ID: 18374938
[TBL] [Abstract][Full Text] [Related]
18. Patch testing of experimentally sensitized beagle dogs: development of a model for skin lesions of atopic dermatitis.
Olivry T; Deangelo KB; Dunston SM; Clarke KB; McCall CA
Vet Dermatol; 2006 Apr; 17(2):95-102. PubMed ID: 16515651
[TBL] [Abstract][Full Text] [Related]
19. Altered cutaneous expression of beta-defensins in dogs with atopic dermatitis.
van Damme CM; Willemse T; van Dijk A; Haagsman HP; Veldhuizen EJ
Mol Immunol; 2009 Aug; 46(13):2449-55. PubMed ID: 19576634
[TBL] [Abstract][Full Text] [Related]
20. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions.
Cork MJ; Robinson DA; Vasilopoulos Y; Ferguson A; Moustafa M; MacGowan A; Duff GW; Ward SJ; Tazi-Ahnini R
J Allergy Clin Immunol; 2006 Jul; 118(1):3-21; quiz 22-3. PubMed ID: 16815133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
